National Institute On Aging (nia)

This study looked at whether emergency room pharmacists can help reduce the use of certain risky medications (like sedatives) in people with dementia or mild memory problems. Researchers worked with 300 patients to see if pharmacists could safely recommend stopping these drugs an…

This study looked at how aging skin cells (senescent cells) appear around small wounds in healthy adults. Researchers compared younger people (ages 20-39) with older adults (70+) to see if there are differences in wound healing. The goal is to better understand aging and age-rela…

This study tested whether a ketone ester supplement, taken for 28 days, could change how the brain uses fuel and affect thinking skills. It included 99 adults aged 55 and older who had metabolic syndrome but no memory problems. Participants were randomly assigned to receive eithe…

This study looked at how two drugs that affect the body's endocannabinoid system (similar to marijuana) influence insulin production and action. 45 healthy men aged 21-55 received different combinations of these drugs or a placebo over four visits. The goal was to understand how …

This study aims to understand why some older adults develop anemia (low red blood cells) without a clear cause. Researchers measured how long red blood cells live in younger and older adults, including those with and without anemia. The study involved 58 participants and used a v…

This study looked at whether giving growth hormone to healthy men aged 25 to 50 could improve their immune system function. Researchers used an infusion pump to deliver either growth hormone or a placebo over several weeks. The goal was to understand how growth hormone affects th…

This study looked at how two drugs, Roflumilast (used for COPD) and Sitagliptin (used for diabetes), affect blood sugar and gut hormones in 29 healthy adults aged 21-55. Participants took the drugs or placebos and had their blood tested after a meal. The goal was to understand ho…

This early-stage study tested a single dose of an experimental drug called BNC in 75 healthy volunteers aged 55 and older. The goal was to see if the drug is safe and how the body processes it, as a first step toward possibly treating Alzheimer's disease. Participants took either…